Healthtech startup Dozee has raised INR 71.5 Cr (~$8.3 Mn) through a combination of equity and debt, aiming to accelerate its international expansion and enhance research & development efforts. According to regulatory filings, Temasek Trust’s C3H invested INR 6.3 Cr in equity, while Stockhausen International Pte Ltd provided INR 58.5 Cr in debt. The remaining funds came from undisclosed strategic investors.

Founded in 2015 by Mudit Dandwate and Gaurav Parchani, Dozee specializes in contactless patient monitoring systems, enabling hospitals to track patients' vital signs remotely, including heart rate, respiration, blood pressure, and temperature. The startup also offers an early warning system to detect health deterioration in patients.

Competing with Zyla Health, Fix Health, Zivov, and Cardiac Design Labs, Dozee has expanded beyond India to the US, UAE, and Africa amid domestic business challenges. With this funding, the company aims to enter new global markets and expand its product portfolio.

Financially, Dozee reduced its net loss by 19% in FY24, reporting INR 68 Cr in losses compared to INR 84.4 Cr in FY23. Meanwhile, revenue grew 148% to INR 5.2 Cr. The company is now focused on achieving profitability and hiring across data science, product, and marketing teams, despite having laid off 40 employees last year to cut costs.